Unmuting large silent genes lets bacteria produce new molecules, potential drug candidates
Credit: Photo by L. Brian Stauffer CHAMPAIGN, Ill. -- By enticing away the repressors dampening unexpressed, silent genes in Streptomyces ...
Tag: Pharmaceutical Science
Patients now living a median 6.8 years after stage IV ALK+ lung cancer diagnosis
According to the National Cancer Institute, patients diagnosed with non-small cell lung cancer (NSCLC) between the years 1995 and 2001 ...
Tumors backfire on chemotherapy
Credit: C. Cianciaruso/I. Keklikoglou/EPFL Some patients with breast cancer receive chemotherapy before the tumor is removed with surgery. This approach, ...
Cell death mechanisms in stroke and novel molecular and cellular treatment options
This article by Dr. Emine Sekerdag et al. is published in Current Neuropharmacology, Volume 16, Issue 9, 2018Credit: Bentham Science ...
Phytochemistry, traditional uses and pharmacological profile of rose hip
This article by Dr. Amirhossein Sahebkar et al. is published in Current Pharmaceutical Design, 2018 The genus Rosa from family ...
Genetic polymorphisms and zinc status
This article by Dr. Angela Polito et al. is published in Current Pharmaceutical Design, 2018 Zinc is one of the ...
Coenzyme Q10 supplementation on metabolic profiles of patients with chronic kidney disease
The article by Dr. Zatollah Asemi et al. is published in Current Pharmaceutical Design, Volume 24, Issue 31, 2018 Chronic ...
The landscape of protein tyrosine phosphatase (Shp2) and cancer
This article by Dr. Hai-Feng Chen et al. is published in Current Pharmaceutical Design, 2018 As the proteomics technology develops ...
Computational advances in the label-free quantification of cancer proteomics data
This article by Dr. Feng Zhu et al. is published in Current Pharmaceutical Design, 2018 In recent years, proteomics research ...
Impact of a psycho-educational team in early breast cancer patients' coping strategies
This article by Dr. Fausto Meriggi et al. is published in Reviews on Recent Clinical Trials, Volume 13, Issue 4, ...
Yale experts treat severe, disfiguring sarcoidosis with novel therapy
New Haven, Conn. -- An all-Yale team of researchers successfully treated a patient with disfiguring sarcoidosis, a chronic disease that ...
Confronting the side effects of a common anti-cancer treatment
UMass Amherst researchers study origins of adverse effects AMHERST, Mass. - Results of a new study by neuroscientists at the ...
Breast cancer drugs could help treat resistant lung cancers
A class of drugs used to treat certain breast cancers could help to tackle lung cancers that have become resistant ...
Novel biomarkers & therapeutic targets for atherosclerotic cardiovascular diseases
The article by Dr. Geoff H. Werstuck et al. is published in Cardiovascular & Hematological Disorders-Drug Targets, Volume 18, Issue ...
Targeting kinetoplastid and apicomplexan thymidylate biosynthesis as antiprotozoal strategy
This article by Dr. Dolores Gonzalez Pacanowska et al. is published in Current Medicinal Chemistry, 2018 Kinetoplastid and apicomplexan parasites ...
Anesthetic-induced myocardial conditioning: Molecular fundamentals and scope
This article by Dr. Jose Luis Guerrero Orriach et al. is published in Current Medicinal Chemistry, 2018 Many studies have ...
Pediatric leukemia 'super drug' could be developed in the coming years
Fourth study published over two-year span that analyzes key leukemia proteinCredit: Northwestern University CHICAGO --- Northwestern Medicine scientists have discovered ...
Preparation, characterization and in vitro biological activity of Soyasapogenol B
This article by Dr. Ahmed A. Haroun et al. is published in Current Bioactive Compounds, Volume 14 , Issue 4 ...
Yale Cancer Center scientists advise caution in immunotherapy research
New Haven, Conn. -- In a new study, Yale Cancer Center (YCC) scientists suggest that as the number of clinical ...
Anticancer vaccines gain new lease of life with personalisation techniques
ESMO Immuno-Oncology Congress, 13-16 December, Geneva, Switzerland Lugano, Switzerland, 19 December 2018 - Anticancer vaccines have gained a new lease ...